Holen Sie sich die Stockscreener-App
1.58
8.67%
-0.15
Schlusskurs vom Vortag:
$1.73
Offen:
$1.7
24-Stunden-Volumen:
327.04K
Relative Volume:
0.53
Marktkapitalisierung:
$64.38M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-0.9875
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
-14.13%
1M Leistung:
-1.86%
6M Leistung:
-69.67%
1J Leistung:
-75.50%
1-Tages-Spanne:
$1.55
$1.73
1-Wochen-Bereich:
$1.55
$1.92
52-Wochen-Spanne:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Firmenname
Pulmonx Corp
Sektor
Branche
Telefon
650-364-0400
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie LUNG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.58 | 70.49M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Eingeleitet | D. Boral Capital | Buy |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-04 | Eingeleitet | Lake Street | Buy |
| 2024-02-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Neutral |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-10-26 | Eingeleitet | BofA Securities | Buy |
| 2020-10-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Eingeleitet | Stifel | Buy |
| 2020-10-26 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Market reaction to Pulmonx Corporation’s recent newsJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Pulmonx (NASDAQ:LUNG) - MarketBeat
Why Pulmonx Corporation stock attracts high net worth investorsPortfolio Growth Summary & Community Verified Trade Signals - newser.com
Heatmap analysis for Pulmonx Corporation and competitorsInflation Watch & Verified Stock Trade Ideas - newser.com
Can Pulmonx Corporation rally from current levelsPrice Action & Real-Time Volume Trigger Notifications - newser.com
Wall Street Zen Downgrades Pulmonx (NASDAQ:LUNG) to Sell - Defense World
Pulmonx (NASDAQ:LUNG) Cut to "Sell" at Wall Street Zen - MarketBeat
Will Pulmonx Corporation benefit from macro trendsWeekly Profit Report & Community Trade Idea Sharing - newser.com
Will Pulmonx Corporation stock go up soonJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Does Pulmonx Corporation show high probability of rebound2025 Momentum Check & Real-Time Market Trend Scan - newser.com
What machine learning models say about Pulmonx CorporationJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Goldman Sachs Group Inc. Has $1.32 Million Holdings in Pulmonx Corporation $LUNG - Defense World
How high can Pulmonx Corporation stock goQuarterly Trade Review & Technical Pattern Based Buy Signals - newser.com
Pulmonx Corporation stock daily chart insights2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Tools to assess Pulmonx Corporation’s risk profile2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
How to recover losses in Pulmonx Corporation stock2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
What earnings revisions data tells us about Pulmonx CorporationJuly 2025 Summary & Daily Price Action Insights - newser.com
How to interpret RSI for Pulmonx Corporation stockEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Investment Review: What is the target price for Pulmonx Corporation stock2025 Macro Impact & Weekly Return Optimization Alerts - خودرو بانک
Will earnings trigger a reversal in Pulmonx CorporationTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Pulmonx Corporation stock trend forecastQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
Forecasting Pulmonx Corporation price range with options dataMarket Trend Summary & High Accuracy Swing Trade Signals - newser.com
Live market analysis of Pulmonx Corporation2025 Key Highlights & Weekly Setup with ROI Potential - newser.com
Insider Trends: Is Pulmonx Corporation stock forming a cup and handleDip Buying & Capital Efficiency Focused Strategies - khodrobank.com
Investor Mood: What’s the RSI of Pulmonx Corporation stock2025 Market Overview & Community Trade Idea Sharing - خودرو بانک
Sentiment analysis tools applied to Pulmonx CorporationPortfolio Return Summary & Low Drawdown Momentum Ideas - newser.com
Combining price and volume data for Pulmonx CorporationPortfolio Performance Report & Fast Entry High Yield Tips - newser.com
Is Pulmonx Corporation building a consolidation baseIndex Update & Weekly High Return Stock Forecasts - newser.com
What MACD signals say about Pulmonx CorporationGold Moves & Breakout Confirmation Trade Signals - newser.com
Finanzdaten der Pulmonx Corp-Aktie (LUNG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pulmonx Corp-Aktie (LUNG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Joshi Mehul | Chief Financial Officer & PAO |
Sep 02 '25 |
Sale |
1.60 |
7,936 |
12,698 |
208,489 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Sep 02 '25 |
Sale |
1.60 |
6,543 |
10,469 |
379,788 |
| Lehman David Aaron | GENERAL COUNSEL |
Sep 02 '25 |
Sale |
1.60 |
9,769 |
15,630 |
263,270 |
| Ferrari Richard | Director |
Jun 12 '25 |
Sale |
3.16 |
8,000 |
25,280 |
87,024 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):